scispace - formally typeset
J

Janet Gardner-Medwin

Researcher at University of Glasgow

Publications -  71
Citations -  3091

Janet Gardner-Medwin is an academic researcher from University of Glasgow. The author has contributed to research in topics: Arthritis & Childhood arthritis. The author has an hindex of 26, co-authored 70 publications receiving 2714 citations. Previous affiliations of Janet Gardner-Medwin include Royal Hospital for Sick Children & Children's of Alabama.

Papers
More filters
Journal ArticleDOI

Incidence of Henoch-Schonlein purpura, Kawasaki disease, and rare vasculitides in children of different ethnic origins

TL;DR: In this paper, the frequency and ethnic variation of Henoch-Schonlein purpura, Kawasaki disease, and rarer vasculitides during childhood are not well characterised.
Journal ArticleDOI

Molecular basis of the spectral expression of CIAS1 mutations associated with phagocytic cell-mediated autoinflammatory disorders CINCA/NOMID, MWS, and FCU.

TL;DR: 7 new mutations in 13 unrelated patients with CINCA syndrome are described and mutational hotspots in CIAS1 are identified on the basis of all mutations described to date, providing evidence of genotype/phenotype correlations and a 3-dimensional model of the nucleotide-binding domain of cryopyrin suggested that this molecule is structurally and functionally similar to members of the AAA+ protein family of ATPases.
Journal ArticleDOI

Diffuse endothelial dysfunction is common to ANCA associated systemic vasculitis and polyarteritis nodosa.

TL;DR: Diffuse endothelial dysfunction, a predictor of atherosclerotic disease, is found extensively in primary systemic vasculitis, and is suggested that this results from a systemic response that may be a consequence of primary vasculation, but is distinct from the local inflammatory vasculitic process.
Journal ArticleDOI

Clinical experience with thalidomide in the management of severe oral and genital ulceration in conditions such as Behçet's disease: use of neurophysiological studies to detect thalidomide neuropathy.

TL;DR: Thalidomide provided a useful therapeutic option in severe oral and genital ulceration which had not responded to other therapies and the physician must remain vigilant to the continuing danger of axonal neuropathy and teratogenesis at all times during thalidomid therapy.